Intelligence · Clinical Development
Pipeline search results
Programs matching “Vertex Pharmaceuticals” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 159 pipeline programs matching "Vertex Pharmaceuticals" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
VX-121
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-135
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
3 trials -
VX-147
Vertex Pharmaceuticals (Australia) Pty.
Glomerulosclerosis, Focal Segmental
1 trial -
VX-150
Vertex Pharmaceuticals (Australia) Pty.
Osteoarthritis
1 trial -
VX-150
Vertex Pharmaceuticals (Australia) Pty.
Acute Pain
2 trials -
VX-150
Vertex Pharmaceuticals (Australia) Pty.
Small Fiber Neuropathy
1 trial -
VX-152
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-222
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C Virus
2 trials -
VX-264
Vertex Pharmaceuticals (Australia) Pty.
Type 1 Diabetes
1 trial -
VX-264 Implant
Vertex Pharmaceuticals (Australia) Pty.
Type 1 Diabetes Mellitus
1 trial -
VX-371
Vertex Pharmaceuticals (Australia) Pty.
Primary Ciliary Dyskinesia
1 trial -
VX-371 + HS
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-407
Vertex Pharmaceuticals (Australia) Pty.
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
4 trials -
VX-407 tablet
Vertex Pharmaceuticals (Australia) Pty.
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
1 trial -
VX-522 mRNA therapy
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-548
Vertex Pharmaceuticals (Australia) Pty.
Painful Lumbosacral Radiculopathy
1 trial -
VX-548
Vertex Pharmaceuticals (Australia) Pty.
Acute Pain
2 trials -
VX-561
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
2 trials -
VX-659
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
2 trials -
VX-661
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
2 trials -
VX-670
Vertex Pharmaceuticals (Australia) Pty.
Myotonic Dystrophy Type 1 (DM1)
2 trials -
VX-670 Solution for Injection/Infusion
Vertex Pharmaceuticals (Australia) Pty.
Myotonic Dystrophy
1 trial -
VX-702
Vertex Pharmaceuticals (Australia) Pty.
Rheumatoid Arthritis
2 trials -
VX-765
Vertex Pharmaceuticals (Australia) Pty.
Psoriasis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.